Cargando…
MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants
Perioperative hypersensitivity (POH) to the neuromuscular blocking drug (NMBD) rocuronium was previously thought to be IgE and mast cell (MC)-mediated. However, the recent seminal observation that rocuronium induces degranulation in murine peritoneal MCs (PMCs) via Mas-related G protein-coupled rece...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830812/ https://www.ncbi.nlm.nih.gov/pubmed/33467419 http://dx.doi.org/10.3390/cells10010156 |
_version_ | 1783641499893760000 |
---|---|
author | Chompunud Na Ayudhya, Chalatip Amponnawarat, Aetas Roy, Saptarshi Oskeritzian, Carole A. Ali, Hydar |
author_facet | Chompunud Na Ayudhya, Chalatip Amponnawarat, Aetas Roy, Saptarshi Oskeritzian, Carole A. Ali, Hydar |
author_sort | Chompunud Na Ayudhya, Chalatip |
collection | PubMed |
description | Perioperative hypersensitivity (POH) to the neuromuscular blocking drug (NMBD) rocuronium was previously thought to be IgE and mast cell (MC)-mediated. However, the recent seminal observation that rocuronium induces degranulation in murine peritoneal MCs (PMCs) via Mas-related G protein-coupled receptor B2 (MrgprB2) led to the idea that POH to this drug involves the activation of MRGPRX2 (human ortholog of MrgprB2). Furthermore, based on the demonstration that a patient with POH to rocuronium displayed three missense mutations (M196I, L226P and L237P) in MRGPRX2’s transmembrane domains, it was proposed that this hypersensitivity reaction resulted from aberrant activation of this receptor. We found that rocuronium at 20 µg/mL caused degranulation in mouse PMCs via MrgprB2 but required at least 500 µg/mL to induce degranulation in human MCs via MRGPRX2. Furthermore, RBL-2H3 cells transiently expressing M196I, L226P and L237P variants did not display enhanced degranulation in response to rocuronium when compared to the wild-type receptor. These findings provide the first demonstration that rocuronium induces degranulation in human MCs via MRGPRX2. Furthermore, the important differences between MrgprB2 and MRGPRX2 and the inability of rocuronium to induce enhanced response in cells expressing MRGPRX2 variants suggest that the mechanism of its POH is more complex than previously thought. |
format | Online Article Text |
id | pubmed-7830812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78308122021-01-26 MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants Chompunud Na Ayudhya, Chalatip Amponnawarat, Aetas Roy, Saptarshi Oskeritzian, Carole A. Ali, Hydar Cells Communication Perioperative hypersensitivity (POH) to the neuromuscular blocking drug (NMBD) rocuronium was previously thought to be IgE and mast cell (MC)-mediated. However, the recent seminal observation that rocuronium induces degranulation in murine peritoneal MCs (PMCs) via Mas-related G protein-coupled receptor B2 (MrgprB2) led to the idea that POH to this drug involves the activation of MRGPRX2 (human ortholog of MrgprB2). Furthermore, based on the demonstration that a patient with POH to rocuronium displayed three missense mutations (M196I, L226P and L237P) in MRGPRX2’s transmembrane domains, it was proposed that this hypersensitivity reaction resulted from aberrant activation of this receptor. We found that rocuronium at 20 µg/mL caused degranulation in mouse PMCs via MrgprB2 but required at least 500 µg/mL to induce degranulation in human MCs via MRGPRX2. Furthermore, RBL-2H3 cells transiently expressing M196I, L226P and L237P variants did not display enhanced degranulation in response to rocuronium when compared to the wild-type receptor. These findings provide the first demonstration that rocuronium induces degranulation in human MCs via MRGPRX2. Furthermore, the important differences between MrgprB2 and MRGPRX2 and the inability of rocuronium to induce enhanced response in cells expressing MRGPRX2 variants suggest that the mechanism of its POH is more complex than previously thought. MDPI 2021-01-15 /pmc/articles/PMC7830812/ /pubmed/33467419 http://dx.doi.org/10.3390/cells10010156 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Chompunud Na Ayudhya, Chalatip Amponnawarat, Aetas Roy, Saptarshi Oskeritzian, Carole A. Ali, Hydar MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants |
title | MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants |
title_full | MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants |
title_fullStr | MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants |
title_full_unstemmed | MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants |
title_short | MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants |
title_sort | mrgprx2 activation by rocuronium: insights from studies with human skin mast cells and missense variants |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830812/ https://www.ncbi.nlm.nih.gov/pubmed/33467419 http://dx.doi.org/10.3390/cells10010156 |
work_keys_str_mv | AT chompunudnaayudhyachalatip mrgprx2activationbyrocuroniuminsightsfromstudieswithhumanskinmastcellsandmissensevariants AT amponnawarataetas mrgprx2activationbyrocuroniuminsightsfromstudieswithhumanskinmastcellsandmissensevariants AT roysaptarshi mrgprx2activationbyrocuroniuminsightsfromstudieswithhumanskinmastcellsandmissensevariants AT oskeritziancarolea mrgprx2activationbyrocuroniuminsightsfromstudieswithhumanskinmastcellsandmissensevariants AT alihydar mrgprx2activationbyrocuroniuminsightsfromstudieswithhumanskinmastcellsandmissensevariants |